Patents by Inventor David Burkhart

David Burkhart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250143349
    Abstract: An ice cream making assembly includes a mixing bowl having an outer housing and an inner liner defining a wall cavity therebetween. The mixing bowl further includes a radiator fin unit received within a portion of the wall cavity and a phase-change medium filling a further portion of the wall cavity surrounding at least a portion of the radiator fin unit. The radiator fin unit defines an outer chamfer extending generally along an outer cross-sectional profile of the wall cavity and a tapered inner profile extending along inner cross-sectional profile of the wall cavity and in at least partial contact with the inner liner. The assembly further includes a dasher including first and second mixing arms extending outwardly from an anchor end of the axle and upwardly and outwardly to generally follow an angled inner profile of the food-product receiving cavity defined by the liner.
    Type: Application
    Filed: December 16, 2024
    Publication date: May 8, 2025
    Applicant: WHIRLPOOL CORPORATION
    Inventors: Prabhjee Anand, Richard D. Arnold, Bryan Scott Burkhart, Christopher J. Eaton, Patrick David Feltman, Timothy E. Heater, Brandon Tyler Mock, Jon Patrick Morris, Nicholas Hill Schutte, Rohit Ranjan Singh
  • Patent number: 12243725
    Abstract: A thermal choke rod connecting a radio frequency source to a substrate support of a plasma processing system includes a tubular member having a first connector for connecting to an RF rod coupled to the substrate support and a second connector for connecting to an RF strap that couples to the RF source. A tubular segment extends between the first and second connectors. The first connector has a conically-shaped end region that tapers away from the inner surface thereof to an outer surface in a direction toward the tubular segment, and slits that extend for a prescribed distance from a terminal end of the first connector. The outer surface of the tubular segment has a threaded region for threaded engagement with an annular cap that fits over the first connector and reduces an inner diameter of the first connector upon contact with the conically-shaped end region of the first connector.
    Type: Grant
    Filed: August 31, 2022
    Date of Patent: March 4, 2025
    Assignee: Lam Research Corporation
    Inventors: Timothy S. Thomas, Vincent Burkhart, Joel Hollingsworth, David French, Damien Slevin
  • Publication number: 20240342297
    Abstract: The invention relates to isolated immunogenic peptides comprising a MHC class II T cell epitope, and immediately adjacent or separated from said epitope a H—X(0,2)-C—X(2)-[CST] or [CST]-X(2)-C—X(0,2)-H redox motif.
    Type: Application
    Filed: May 24, 2024
    Publication date: October 17, 2024
    Inventors: Jean-Marie SAINT-REMY, Vincent CARLIER, Luc VANDER ELST, David BURKHART
  • Publication number: 20240325517
    Abstract: Multivalent conjugates and conjugate compositions of peptides derived from the CoaB coat protein of Pseudomonas aeruginosa filamentous (Pf) bacteriophage and conjugates adjuvanted with a TLR 4 and/or TLR 7/8 agonist induce and/or enhance an immune response toward Pseudomonas aeruginosa filamentous (Pf) bacteriophage. The conjugates, compositions, and vaccines have utility to reduce, prevent and/or ameliorate the adverse effect of Pseudomonas aeruginosa infection, such as biofilm formation.
    Type: Application
    Filed: September 15, 2021
    Publication date: October 3, 2024
    Inventors: Patrick Secor, Jay Evans, David Burkhart
  • Publication number: 20240309037
    Abstract: Disclosed herein are diaryl trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Application
    Filed: February 9, 2024
    Publication date: September 19, 2024
    Inventors: David Burkhart, George Ettenger, Jay Evans, Kendal T. Ryter, Alyson Smith
  • Patent number: 12023384
    Abstract: The invention relates to isolated immunogenic peptides comprising a MHC class II T cell epitope, and immediately adjacent or separated from said epitope a H-X(0,2)-C-X(2)-[CST] or [CST]-X(2)-C-X(0,2)-H redox motif.
    Type: Grant
    Filed: June 4, 2020
    Date of Patent: July 2, 2024
    Assignee: IMCYSE SA
    Inventors: Jean-Marie Saint-Remy, Vincent Carlier, Luc Vander Elst, David Burkhart
  • Patent number: 11964014
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: April 23, 2024
    Assignee: THE UNIVERSITY OF MONTANA
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Patent number: 11912736
    Abstract: Disclosed herein are diaryl trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Grant
    Filed: February 21, 2019
    Date of Patent: February 27, 2024
    Assignee: THE UNIVERSITY OF MONTANA
    Inventors: David Burkhart, George Ettenger, Jay Evans, Kendal T. Ryter, Alyson Smith
  • Publication number: 20240024469
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmune disorders.
    Type: Application
    Filed: August 8, 2023
    Publication date: January 25, 2024
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Publication number: 20230310438
    Abstract: Provided herein are TLR7/8 agonists to enhance immune responses or for use as adjuvants in fentanyl vaccines in opioid-using individuals.
    Type: Application
    Filed: October 16, 2020
    Publication date: October 5, 2023
    Applicants: Children's Medical Center Corporation, the University of Montana, Regents of the University of Minnesota
    Inventors: David J. Dowling, Ofer Levy, Dheeraj Soni, Sharon Levy, Jay Evans, Marco Pravetoni, David Burkhart, Shannon Miller
  • Publication number: 20230297953
    Abstract: Devices, systems, and methods for unloading a tractor trailer that is loaded with assets are disclosed herein. An example method includes reading a unique identifier that is associated with each asset in the tractor trailer, the unique identifier including asset information. The method includes receiving indicia of the asset information, receiving a manual input of the asset information, and/or for choosing the asset information manually from a list of reference data displayed on the display device. The method includes performing a data comparison of the asset information with reference data stored on the storage to thereby identify the asset in an inventory associated with the reference data. The method includes modifying the inventory based on the data comparison when the asset has reached a destination.
    Type: Application
    Filed: February 13, 2023
    Publication date: September 21, 2023
    Inventors: Tim Plonski, David Burkhart
  • Patent number: 11572381
    Abstract: Disclosed herein are immunogenic trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Grant
    Filed: March 1, 2019
    Date of Patent: February 7, 2023
    Assignee: The University of Montana
    Inventors: David Burkhart, Jay Evans, Craig Johnson, Kendal T. Ryter, Alyson Smith, Walid Abdelwahab Marzouky Abdelwahab
  • Patent number: 11464854
    Abstract: The methods and compositions described herein relate to methods of immunization or stimulating an immune response, e.g., using agonists of TLR7 and/or TLR8 as antigens. The methods and compositions described herein have particular relevance to use in infants.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: October 11, 2022
    Assignees: Children's Medical Center Corporation, University of Montana
    Inventors: Ofer Levy, David Dowling, Helene Bazin-Lee, David Burkhart, Jay Evans, Alyson Jessica Smith
  • Publication number: 20220241410
    Abstract: Lipidated oxoadenines of formula (I) are TLR7/8 receptor ligands useful for modulating immune responses. The compounds may have therapeutic application in the treatment of cancer, infectious diseases, allergy, or autoimmnune disorders.
    Type: Application
    Filed: May 22, 2020
    Publication date: August 4, 2022
    Inventors: Helene Bazin-Lee, David Burkhart, Jay Evans
  • Publication number: 20220144865
    Abstract: This invention relates inter alia to novel imidazoquinoline derivatives and their use in therapy, particularly as vaccine adjuvants.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Helene G. BAZIN-LEE, Jay T. EVANS, David BURKHART, Michael COCHRAN, David A. JOHNSON
  • Publication number: 20220144833
    Abstract: This invention relates inter alia to novel imidazoquinoline derivatives and their use in therapy, particularly as vaccine adjuvants.
    Type: Application
    Filed: January 24, 2022
    Publication date: May 12, 2022
    Applicant: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Helene G. BAZIN-LEE, Jay T. EVANS, David BURKHART, Michael COCHRAN, David A. JOHNSON
  • Patent number: 11274115
    Abstract: This invention relates inter alia to novel imidazoquinoline derivatives and their use in therapy, particularly as vaccine adjuvants.
    Type: Grant
    Filed: September 5, 2017
    Date of Patent: March 15, 2022
    Assignee: GLAXOSMITHKLINE BIOLOGICAL SA
    Inventors: Helene G. Bazin-Lee, Jay T. Evans, David Burkhart, Michael Cochran, David A. Johnson
  • Patent number: 11207404
    Abstract: The present invention relates to immunogenic compositions and methods for producing them, and in particular, immunogenic compositions comprising a protein antigen cross linked to an oxoadenine adjuvant.
    Type: Grant
    Filed: April 15, 2020
    Date of Patent: December 28, 2021
    Assignee: GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: David Burkhart, Michael Cochran, Christopher W Cluff, Daniel Larocque, Helene G. Bazin-Lee, Julien St-Jean
  • Publication number: 20210277038
    Abstract: This invention relates inter alia to novel imidazoquinoline derivatives and their use in therapy, particularly as vaccine adjuvants.
    Type: Application
    Filed: September 5, 2016
    Publication date: September 9, 2021
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Helene G. BAZIN-LEE, Jay T. EVANS, David BURKHART, Michael COCHRAN, David A. JOHNSON
  • Publication number: 20210139521
    Abstract: Disclosed herein are diaryl trehalose compounds and methods of use thereof, for example as vaccine adjuvants.
    Type: Application
    Filed: February 21, 2019
    Publication date: May 13, 2021
    Inventors: David Burkhart, George Ettenger, Jay Evans, Kendal T. Ryter, Alyson Smith